CELLVERA Trademark

Trademark Overview


On Thursday, March 17, 2022, a trademark application was filed for CELLVERA with the United States Patent and Trademark Office. The USPTO has given the CELLVERA trademark a serial number of 97317740. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, July 30, 2024. This trademark is owned by Cellvera Global Holdings LLC. The CELLVERA trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Drugs and pharmaceuticals in the form of solids, namely, capsules, medicated candy, tablets and liquids for the treatment of flu, viral infections including Covid-19, bacterial infections, diabetes, cancer, HIV, ulcers, high blood pressure, high cholesterol, seizures, epilepsy, muscle and joint pain; Pharmaceutical preparations, namely, pills for killing viruses, bacteria, coronaviruses including COVID-19, biofilms, fungi, mold, and spores, and for the treatment and prevention of diabetes; Pharmaceutical preparations, namely, anti-infectives for use in or as chemotherapeutics; pharmaceutical preparations for the treatment of viral diseases for use in or as chemotherapeutics; Disinfectants; Sanitizing preparations for household, commercial, and hospital use; all purpose disinfectants for killing viruses, bacteria, coronaviruses including COVID-19, biofilms, fungi, mold, and spores

Pharmaceutical products development; Pharmaceutical research and development; Pharmaceutical drug development services; Development of pharmaceutical preparations and medicines for killing viruses, bacteria, coronaviruses including COVID-19, biofilms, fungi, mold, and spores, and for the treatment and prevention of diabetes; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Testing of pharmaceuticals
cellvera

General Information


Serial Number97317740
Word MarkCELLVERA
Filing DateThursday, March 17, 2022
Status688 - NOTICE OF ALLOWANCE - ISSUED
Status DateTuesday, July 30, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, June 4, 2024

Trademark Statements


Description of MarkThe mark consists of the wording "CELLVERA" in a stylized font to the right of a circle consisting of small circles.
Goods and ServicesDrugs and pharmaceuticals in the form of solids, namely, capsules, medicated candy, tablets and liquids for the treatment of flu, viral infections including Covid-19, bacterial infections, diabetes, cancer, HIV, ulcers, high blood pressure, high cholesterol, seizures, epilepsy, muscle and joint pain; Pharmaceutical preparations, namely, pills for killing viruses, bacteria, coronaviruses including COVID-19, biofilms, fungi, mold, and spores, and for the treatment and prevention of diabetes; Pharmaceutical preparations, namely, anti-infectives for use in or as chemotherapeutics; pharmaceutical preparations for the treatment of viral diseases for use in or as chemotherapeutics; Disinfectants; Sanitizing preparations for household, commercial, and hospital use; all purpose disinfectants for killing viruses, bacteria, coronaviruses including COVID-19, biofilms, fungi, mold, and spores
Pseudo MarkCELL VERA
Goods and ServicesPharmaceutical products development; Pharmaceutical research and development; Pharmaceutical drug development services; Development of pharmaceutical preparations and medicines for killing viruses, bacteria, coronaviruses including COVID-19, biofilms, fungi, mold, and spores, and for the treatment and prevention of diabetes; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Testing of pharmaceuticals

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, March 22, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, March 22, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameCellvera Global Holdings LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressLewes, DE 19958

Party NameCellvera Global Holdings LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressLewes, DE 19958

Trademark Events


Event DateEvent Description
Tuesday, March 22, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, March 21, 2022NEW APPLICATION ENTERED
Wednesday, March 23, 2022NOTICE OF DESIGN SEARCH CODE E-MAILED
Wednesday, January 4, 2023ASSIGNED TO EXAMINER
Tuesday, January 10, 2023NON-FINAL ACTION WRITTEN
Tuesday, January 10, 2023NON-FINAL ACTION E-MAILED
Tuesday, January 10, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, May 31, 2023ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Thursday, August 31, 2023NOTICE OF REVIVAL - E-MAILED
Wednesday, May 31, 2023ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Wednesday, May 31, 2023ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Thursday, August 31, 2023TEAS PETITION TO REVIVE RECEIVED
Thursday, August 31, 2023PETITION TO REVIVE-GRANTED
Thursday, August 31, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, September 1, 2023NOTICE OF REVIVAL - E-MAILED
Monday, January 22, 2024ASSIGNED TO LIE
Monday, January 22, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, January 22, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, January 26, 2024FINAL REFUSAL WRITTEN
Friday, January 26, 2024FINAL REFUSAL E-MAILED
Friday, January 26, 2024NOTIFICATION OF FINAL REFUSAL EMAILED
Friday, April 26, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, April 26, 2024TEAS REQUEST FOR RECONSIDERATION RECEIVED
Saturday, April 27, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, April 29, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 15, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 4, 2024PUBLISHED FOR OPPOSITION
Tuesday, June 4, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 30, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT